Skip to main content
. 2010 Jun 1;8:46. doi: 10.1186/1477-7819-8-46

Table 4.

Survival data in 76 esophageal cancer patients (time in months).

Surgery 95% CI CRT + Surgery 95% CI p
No. of patients 45 31
Overall survival (median) 11.1 7.63 - 14.53 31.4 11.90-50.98 0.042
Disease-specific survival (median) 11.1 7.63 - 14.53 34.4 6.88-61.91 0.019
Progression free survival (median) 9.5 7.36 - 11.63 18.0 8.48 - 27.52 0.064
DMFS (median) 9.6 6.75 - 12.50 17.94 6.39 - 29.48 0.058
# LR free survival (median) X X 0.67
Patients free of LR after 3 years 69% 71%
Patients free of LR after 5 years 61% 71%
1 year overall survival rate 44% 68%
3 year overall survival rate 24% 44%
5 year overall survival rate 16% 29%

Confidence interval. Chemoradiotherapy. Distant metastasis free survival. # Local recurrence. X = not reached. Local recurrence free survival stands for survival from treatment start until disease recurrence in the field of radiotherapy and/or field of surgery in the mediastinum.